Search results
Results From The WOW.Com Content Network
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
On 19 December 2006, the majority of shareholders voted to approve the sale of the pharmaceuticals division to the Danish company Nycomed. [7] Nycomed is owned by an investment consortium led by Nordic Capital and Credit Suisse. With the sale of the pharmaceuticals division, headquartered in Konstanz, Germany, Altana lost a major pillar of its ...
Solvay is a Belgian multinational chemical company established in 1863, with its headquarters located in Neder-Over-Heembeek, Brussels, Belgium. Since the end of 2023, following its demerger with the creation of the new Syensqo entity, Solvay has specialized in essential chemistry and employs over 9,000 people in 40 countries.
For premium support please call: 800-290-4726 more ways to reach us
In 1999, the therapeutics company was established under the name Nycomed as an independent company. In 2007, Nycomed took over the much larger German pharmaceutical company, Altana Pharma. This acquisition made Nycomed one of the world's 25 largest pharmaceutical companies. In 2007 Nycomed acquired American company Bradley Pharmaceuticals.
On Friday, December 8, 2023, [12] shareholders approved the plan to split Solvay into two separate entities. [13] [14] As a result, Ilham Kadri, former CEO of Solvay, is the CEO of Syensqo, whereas Philippe Kehren becomes CEO of Solvay. [15] The split became effective on December 11th, 2023, with shares listed on Euronext Brussels and Euronext ...
For premium support please call: 800-290-4726 more ways to reach us
FTC scrutiny. The FTC's track record on pharma deals isn't great. It previously tried, unsuccessfully, to block Amgen’s $28 billion acquisition of Horizon Therapeutics.It asked for more details ...